Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 92 of 1,261
  1. US 12098118

    Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction

    Regents of the University of Minnesota · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  2. US 12097306

    Conformal coating of biological surfaces

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  3. US 12097223

    Mesenchymal stromal cells and uses related thereto

    Astellas Institute for Regenerative Medicine · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  4. US 12097263

    Muscle targeting complexes and uses thereof for treating myotonic dystrophy

    Dyne Therapeutics, Inc. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  5. US 12097262

    mTORC1 inhibitors

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  6. US 12097196

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  7. US 12098141

    Bicyclic indazole glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  8. US 12097264

    Methods and compositions for theranostic nanoparticles

    Sanford Burnham Prebys Medical Discovery Institute at Lake Nona · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  9. US 12097199

    Administration of SUMO-activating enzyme inhibitor and anti-CD20 antibodies

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  10. US 12098116

    Crystalline prostacyclin (IP) receptor agonist and uses thereof

    United Therapeutics Corporation · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  11. US 12098144

    Piperazine indazole glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  12. US 12098215

    Fusion protein construct

    Northwestern University · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  13. US 12098155

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  14. US 12098385

    Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  15. WO 2024188802

    PROCÉDÉS D'ISOLEMENT DE POXVIRUS À PARTIR DE CULTURES DE CELLULES AVIAIRES

    BAVARIAN NORDIC AS [DK] · Granted Sep 19, 2024 · Expires Sep 14, 2044

    granted
  16. WO 2024188803

    PRODUCTION DE POXVIRUS À PARTIR DE CULTURES DE CELLULES DE CAILLE

    BAVARIAN NORDIC AS [DK] · Granted Sep 19, 2024 · Expires Sep 14, 2044

    granted
  17. US 2024307628

    SYSTEMS AND METHODS FOR DELIVERY OF LIQUID PHARMACEUTICAL COMPOSITIONS IN PARTICULAR COMPRISING ONE OR MORE SGLT-2 INHIBITOR(S)

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Sep 19, 2024 · Expires Sep 14, 2044

    granted
  18. WO 2024188801

    UTILISATION DE LIGNÉES CELLULAIRES DE CAILLE POUR PRODUCTION DE POXVIRUS

    BAVARIAN NORDIC AS [DK] · Granted Sep 19, 2024 · Expires Sep 14, 2044

    granted
  19. US 12091388

    Solid state forms of Reproxalap

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  20. US 12091386

    D-amphetamine compounds, compositions, and processes for making and using the same

    Zevra Therapeutics, Inc. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  21. US 12091410

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  22. US 12090156

    Application of CB-839 in preparation of drug for inhibiting corneal neovascularization (CNV)

    INSTITUTE OF OPHTHALMOLOGY AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG INSTITUTE OF OPHTHALMO · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  23. US 12091666

    Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  24. US 12091440

    IL2 and peptide-MHC complex fusion proteins and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.